Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections.
Lassa fever
Lassa mammarenavirus
Lassa virus
Nigeria
concomitant infections
dexamethasone
ribavirin
viral hemorrhagic fever
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
ppublish
Résumé
Lassa fever is a viral hemorrhagic fever treated with supportive care and the broad-spectrum antiviral drug ribavirin. The pathophysiology, especially the role of hyperinflammation, of this disease is unknown. We report successful remission of complicated Lassa fever in 2 patients in Nigeria who received the antiinflammatory agent dexamethasone and standard ribavirin.
Identifiants
pubmed: 36148915
doi: 10.3201/eid2810.220625
pmc: PMC9514364
doi:
Substances chimiques
Antiviral Agents
0
Ribavirin
49717AWG6K
Dexamethasone
7S5I7G3JQL
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2060-2063Références
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
PLoS Negl Trop Dis. 2021 Jul 8;15(7):e0009522
pubmed: 34237063
BMJ Open. 2020 Apr 16;10(4):e036936
pubmed: 32303517
Lancet Glob Health. 2021 Apr;9(4):e469-e478
pubmed: 33740408
PLoS Negl Trop Dis. 2020 Aug 26;14(8):e0008589
pubmed: 32845889
Int J Infect Dis. 2019 Oct;87:15-20
pubmed: 31357056
J Infect Dis. 2001 Aug 1;184(3):345-9
pubmed: 11443561
Lancet Infect Dis. 2021 Jun;21(6):876-886
pubmed: 33484646
N Engl J Med. 1986 Jan 2;314(1):20-6
pubmed: 3940312
Case Rep Neurol. 2018 Jul 3;10(2):150-158
pubmed: 30057542
J Virol. 2020 Oct 14;94(21):
pubmed: 32817220